People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| QoL meds Holding Company, LLC | — | Other | Series C | $84.0M | $1.4B | 2014 |
Christopher Corey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher Corey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James F. Smith | 1 | 5 |
| Daniel Sassano | 1 | 3 |
| Victor Breed | 1 | 2 |
| Christopher Crosby | 1 | 2 |
| Douglas Present | 1 | 2 |
| John Figueroa | 1 | 2 |
| Richard F. Rizzo | 1 | 2 |
| Mark F. Peterson | 1 | 1 |
| Scott Hilinski | 1 | 1 |
| Donald F. Mays | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.